ARK Innovation ETF: What's Next for Africa's Growth?
Africa's digital economy is rapidly expanding, creating demand for cutting-edge technologies in finance, healthcare, and energy. This basket offers potential exposure to US-listed companies leading the disruptive innovation trends that are shaping the continent's future.
Your Basket's Financial Footprint
Concise summary of the basket's total market capitalisation and dominance of large-cap holdings.
- Large-cap dominance suggests generally lower volatility and returns that broadly track the market rather than idiosyncratic swings.
- Suitable as a core portfolio holding for steady exposure, not as a speculative or short-term trade.
- Likely to deliver gradual, long-term growth; large-cap anchoring makes explosive short-term gains less likely.
V: $668.94B
MA: $517.12B
JMIA: $1.31B
- Other
About This Group of Stocks
Our Expert Thinking
Africa's digital economy is booming, creating massive demand for the same disruptive technologies that ARK Innovation ETF companies pioneer. From digital payments to AI and healthcare solutions, these global innovators are building the infrastructure that's powering the continent's transformation. This basket captures US-listed firms whose technologies are becoming essential to Africa's growth story.
What You Need to Know
This theme focuses on established US companies rather than African startups, offering exposure to the global tech giants that African businesses and consumers increasingly rely on. These are the firms developing the software, hardware, and platforms being deployed across African markets. It's a way to invest in Africa's digital future through proven international leaders.
Why These Stocks
Each company was selected for its role in driving the kind of disruptive innovation that's reshaping Africa. Whether it's payment processing, medical technology, or AI development, these firms are creating the foundational technologies that Nigerian startups and other African businesses use to serve their growing markets. They're the enablers of African progress.
Why You'll Want to Watch These Stocks
Africa's Digital Revolution
The continent's rapid digitalisation is creating unprecedented demand for the exact technologies these companies provide. You're watching the infrastructure builders of Africa's future economy.
Innovation Meets Opportunity
These aren't just tech stocks - they're the global pioneers whose platforms and solutions are becoming essential to African businesses and consumers. The innovation is proven, the market is exploding.
Global Giants, Local Impact
From payment processing to healthcare technology, these established companies are the backbone supporting Africa's startup ecosystem and digital transformation. Their success directly benefits from the continent's growth.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Automotive Semiconductor Gap Explained | Market Shift
A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.
Brazil Smart Farming Tech Investment Basket 2025
As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.
Weight-Loss Drug M&A: Valuation Risk Concerns
Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.